Susceptibility to Mycobacterium tuberculosis infection

At a Glance

Susceptibility to Mycobacterium tuberculosis infection refers to the state where the possibility of being infected with Mycobacterium tuberculosis or progressing to tuberculosis after infection varies from person to person.

Even with infection, there may be no symptoms; however, if it progresses to active tuberculosis, persistent cough, fever, night sweats, weight loss, or symptoms related to the involved organs may occur.

How the Disease Works

Related factors include exposure to Mycobacterium tuberculosis, immune status, age, comorbidities, nutritional status, and living environment.

Susceptibility to Mycobacterium tuberculosis infection is related to the immune system's ability to control inhaled bacilli and differences in whether the infection remains latent or progresses to active tuberculosis.

Patterns Vary by Person

Immunosuppression, HIV infection, diabetes, old age or infancy, malnutrition, crowded environments, and close contact with tuberculosis patients can increase the risk of infection or disease progression.

Broad framework of diagnosis and management

After exposure to Mycobacterium tuberculosis, one may not become infected, remain with an asymptomatic latent infection, or progress to active tuberculosis; the course varies depending on the individual's immune status.

Diagnosis is determined by comprehensively evaluating exposure history and symptoms, along with tuberculosis infection tests, chest imaging, and, if necessary, microbiological examination of sputum or other specimens.

Current stage of treatment

Tests to confirm Mycobacterium tuberculosis infection may not be able to distinguish between latent infection and active disease alone, and negative results can also be influenced by the timing of the test and immune status.

Management is carried out by confirming infection status and the possibility of active disease, assessing transmission risk and comorbidities, and then linking necessary treatment with contact evaluation.

Treatment varies depending on whether it is a latent infection or active tuberculosis, and based on drug susceptibility results and the patient's clinical situation, so individualized evaluation is required.

How to read clinical trials

Follow-up involves monitoring symptoms, imaging or microbiological responses, drug side effects, and medication adherence; effectiveness or whether it constitutes standard treatment should not be determined solely by the initial results of clinical trials.

Points to verify in clinical encounters

In clinical practice, it is helpful to assess exposure to Mycobacterium tuberculosis, travel and residence history, past testing and treatment, current symptoms, immunosuppressive drugs and comorbidities, as well as pregnancy potential and drug side effects.